• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症细胞因子在酒精性肝病中的作用。

The effect of inflammatory cytokines in alcoholic liver disease.

机构信息

Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

出版信息

Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9.

DOI:10.1155/2013/495156
PMID:24385684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3872233/
Abstract

Alcohol is the most common cause of liver disease in the world. Chronic alcohol consumption leads to hepatocellular injury and liver inflammation. Inflammatory cytokines, such as TNF-α and IFN-γ, induce liver injury in the rat model of alcoholic liver disease (ALD). Hepatoprotective cytokines, such as IL-6, and anti-inflammatory cytokines, such as IL-10, are also associated with ALD. IL-6 improves ALD via activation of the signal transducer and activator of transcription 3 (STAT3) and the subsequent induction of a variety of hepatoprotective genes in hepatocytes. IL-10 inhibits alcoholic liver inflammation via activation of STAT3 in Kupffer cells and the subsequent inhibition of liver inflammation. Alcohol consumption promotes liver inflammation by increasing translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells through the LPS/Toll-like receptor (TLR) 4 pathways. Oxidative stress and microflora products are also associated with ALD. Interactions between pro- and anti-inflammatory cytokines and other cytokines and chemokines are likely to play important roles in the development of ALD. The present study aims to conduct a systemic review of ALD from the aspect of inflammation.

摘要

酒精是世界范围内导致肝脏疾病的最常见原因。慢性酒精摄入可导致肝细胞损伤和肝脏炎症。在酒精性肝病(ALD)大鼠模型中,炎性细胞因子如 TNF-α和 IFN-γ可诱导肝损伤。肝保护细胞因子如 IL-6 和抗炎细胞因子如 IL-10 也与 ALD 相关。IL-6 通过激活信号转导和转录激活因子 3(STAT3)并随后诱导肝细胞中多种肝保护基因的表达来改善 ALD。IL-10 通过在枯否细胞中激活 STAT3 并随后抑制肝脏炎症来抑制酒精性肝炎症。酒精摄入通过增加肠道来源的内毒素向门静脉循环的易位并通过 LPS/Toll 样受体(TLR)4 途径激活枯否细胞来促进肝脏炎症。氧化应激和微生物群落产物也与 ALD 相关。促炎和抗炎细胞因子以及其他细胞因子和趋化因子之间的相互作用可能在 ALD 的发展中发挥重要作用。本研究旨在从炎症角度对 ALD 进行系统综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/fe15369e209a/MI2013-495156.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/0177a2c306e7/MI2013-495156.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/fe8cf5df7166/MI2013-495156.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/a59a0e5d49b7/MI2013-495156.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/fe15369e209a/MI2013-495156.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/0177a2c306e7/MI2013-495156.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/fe8cf5df7166/MI2013-495156.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/a59a0e5d49b7/MI2013-495156.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e40/3872233/fe15369e209a/MI2013-495156.004.jpg

相似文献

1
The effect of inflammatory cytokines in alcoholic liver disease.炎症细胞因子在酒精性肝病中的作用。
Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9.
2
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).酒精性肝病的治疗策略:聚焦于炎症和纤维化(综述)。
Int J Mol Med. 2017 Aug;40(2):263-270. doi: 10.3892/ijmm.2017.3015. Epub 2017 Jun 9.
3
Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.酒精性肝病中的肝保护和抗炎细胞因子。
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2(Suppl 2):89-93. doi: 10.1111/j.1440-1746.2011.07003.x.
4
Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.酒精性肝病的分子机制:固有免疫与细胞因子。
Alcohol Clin Exp Res. 2011 May;35(5):787-93. doi: 10.1111/j.1530-0277.2010.01399.x. Epub 2011 Feb 1.
5
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.非酒精性或酒精性脂肪性肝炎所致肝损伤发展进程中的常见致病机制。
J Toxicol Sci. 2007 Dec;32(5):453-68. doi: 10.2131/jts.32.453.
6
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
7
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.酒精性肝病的发病机制:氧化代谢的作用。
World J Gastroenterol. 2014 Dec 21;20(47):17756-72. doi: 10.3748/wjg.v20.i47.17756.
8
Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis.人参皂苷 Rk3 通过抑制炎症、氧化应激和细胞凋亡对慢性酒精性肝损伤的保护作用。
Food Chem Toxicol. 2019 Apr;126:277-284. doi: 10.1016/j.fct.2019.02.032. Epub 2019 Feb 28.
9
Baicalin Attenuates Alcoholic Liver Injury through Modulation of Hepatic Oxidative Stress, Inflammation and Sonic Hedgehog Pathway in Rats.黄芩苷通过调节大鼠肝脏氧化应激、炎症和音猬因子信号通路减轻酒精性肝损伤。
Cell Physiol Biochem. 2016;39(3):1129-40. doi: 10.1159/000447820. Epub 2016 Aug 29.
10
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.酒精性和非酒精性脂肪性肝炎的进展:固有免疫系统和氧化应激的共同代谢方面。
Drug Metab Pharmacokinet. 2011;26(1):30-46. doi: 10.2133/dmpk.dmpk-10-rv-087. Epub 2010 Dec 7.

引用本文的文献

1
Aqueous Extract of Freshwater Clam Increases Alcohol Metabolism in Rats in a Preclinical Model.淡水蛤水提取物在临床前模型中提高大鼠酒精代谢能力。
Nutrients. 2025 Jun 3;17(11):1915. doi: 10.3390/nu17111915.
2
Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease.酒精性肝病中的免疫机制及新兴治疗靶点
Cell Mol Immunol. 2025 May 21. doi: 10.1038/s41423-025-01291-w.
3
p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction.对异丙基甲苯抑制促纤维化和炎症介质以预防肝功能障碍。

本文引用的文献

1
Innate immunity and alcoholic liver disease.先天性免疫与酒精性肝病。
Dig Dis. 2012;30 Suppl 1(Suppl 1):55-60. doi: 10.1159/000341126. Epub 2012 Oct 11.
2
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice.Toll 样受体 3 的激活通过刺激枯否细胞和星状细胞产生白细胞介素-10 来减轻小鼠的酒精性肝损伤。
J Hepatol. 2013 Feb;58(2):342-9. doi: 10.1016/j.jhep.2012.09.016. Epub 2012 Sep 27.
3
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
Open Life Sci. 2025 Apr 15;20(1):20221054. doi: 10.1515/biol-2022-1054. eCollection 2025.
4
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury.水飞蓟(水飞蓟素)的给药方法是否需要改变?针对肝损伤的随机试验的新观点和荟萃分析。
BMC Complement Med Ther. 2025 Apr 12;25(1):134. doi: 10.1186/s12906-025-04886-y.
5
Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations.酒精性肝病细胞模型中的氧化应激:姜黄素纳米制剂的保护作用
Sci Rep. 2025 Mar 5;15(1):7752. doi: 10.1038/s41598-025-91139-0.
6
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease.肠道和肝脏巨噬细胞在酒精性肝病发病机制中的起源、功能及意义
Cells. 2025 Jan 30;14(3):207. doi: 10.3390/cells14030207.
7
Sex-specific transcriptome similarity networks elucidate comorbidity relationships.性别特异性转录组相似性网络阐明了共病关系。
bioRxiv. 2025 Jan 24:2025.01.22.634077. doi: 10.1101/2025.01.22.634077.
8
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease.酒精性肝病发病机制中的细胞间和器官间串扰。
eGastroenterology. 2024 Oct;2(4). doi: 10.1136/egastro-2024-100104. Epub 2024 Dec 9.
9
Therapeutic Potential of FB091 in Alleviating Alcohol-Induced Liver Disease through Gut-Liver Axis.FB091 通过肠-肝轴缓解酒精性肝病的治疗潜力。
J Microbiol Biotechnol. 2024 Oct 28;34(10):2100-2111. doi: 10.4014/jmb.2407.07051. Epub 2024 Aug 9.
10
Polyphenols improve non-alcoholic fatty liver disease via gut microbiota: A comprehensive review.多酚通过肠道微生物群改善非酒精性脂肪性肝病:综述
Food Sci Nutr. 2024 Jun 7;12(8):5341-5356. doi: 10.1002/fsn3.4178. eCollection 2024 Aug.
白细胞介素-1 受体拮抗剂可改善小鼠炎症小体依赖性酒精性脂肪性肝炎。
J Clin Invest. 2012 Oct;122(10):3476-89. doi: 10.1172/JCI60777. Epub 2012 Sep 4.
4
Alcoholic liver disease: pathogenesis and new therapeutic targets.酒精性肝病:发病机制与新的治疗靶点。
Gastroenterology. 2011 Nov;141(5):1572-85. doi: 10.1053/j.gastro.2011.09.002. Epub 2011 Sep 12.
5
An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.单核细胞趋化蛋白-1 在酒精性肝损伤中的重要作用:在小鼠中调节促炎细胞因子和肝脂肪变性。
Hepatology. 2011 Dec;54(6):2185-97. doi: 10.1002/hep.24599.
6
Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.炎症相关的白细胞介素-6/信号转导子和转录激活子 3 激活可改善白细胞介素-10 缺陷型小鼠的酒精性和非酒精性脂肪性肝病。
Hepatology. 2011 Sep 2;54(3):846-56. doi: 10.1002/hep.24517.
7
The unfolding web of innate immune dysregulation in alcoholic liver injury.酒精性肝损伤中先天免疫失调的展开网络。
Alcohol Clin Exp Res. 2011 May;35(5):782-6. doi: 10.1111/j.1530-0277.2010.01398.x. Epub 2011 Feb 1.
8
Enteric dysbiosis associated with a mouse model of alcoholic liver disease.酒精性肝病小鼠模型相关的肠道菌群失调。
Hepatology. 2011 Jan;53(1):96-105. doi: 10.1002/hep.24018. Epub 2010 Dec 10.
9
Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.细胞因子调节剂 Y-40138 在大鼠酒精性肝病模型中的治疗效果。
J Gastroenterol Hepatol. 2011 Apr;26(4):775-83. doi: 10.1111/j.1440-1746.2011.06658.x.
10
Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease.在酒精性肝病中,巨噬细胞中 microRNA-155 的上调通过增加 mRNA 半衰期促进肿瘤坏死因子 {alpha}(TNF{alpha})的产生。
J Biol Chem. 2011 Jan 14;286(2):1436-44. doi: 10.1074/jbc.M110.145870. Epub 2010 Nov 9.